《医疗合成制品工厂》制药厂有限公司
二十年以年来一直将药品的质量、安全和疗效放在首位
俄罗斯进行医药产品的开发和生产

A full-cycle biotechnological enterprise «Zavod Medsintez» LLC was founded in 2003 in Novouralsk, Sverdlovsk Region, and specializes in the development and production of pharmaceutical products.

Medsintez plant - basic enterprise research and innovation biomedical industrial park «Novouralsky». 2015

A unique drug is produced in the Sverdlovsk region. Efficiency has been confirmed: thanks to its use, more than 10 thousand children have already been born. Reportage «Vesti», Russia 1. 2022

Inauguration of a workshop for the production of biotechnological substances for the reproductive health of women at the Medsintez Plant. Reportage NVK. 2022

Import-substituting production at the Medsintez Plant. Reportage «Vesti», Russia 1. 2022

Dmitry Khubezov, Chairman of the State Duma Committee on Health Protection of the Russian Federation, visited the import-substituting production of the Medsintez plant. Reportage NVK. 2022

Production of the first Russian drug of human follicle stimulating hormone for the treatment of infertility "Primapur" at the Medsintez plant. Reportage NVK. 2021

International experience in the use of the drug "Triazavirin" in the fight against a new coronavirus infection. Press conference TASS. 2020

Alexei Orlov, First Deputy Governor of the Sverdlovsk Region, highly appreciated the potential of the Medsintez plant in the fight against COVID-19. Reportage NVK. 2020

Video lesson for vocational guidance of schoolchildren about the pharmaceutical enterprise the Medsintez plant as part of the Unified Industrial Map project. 2019

Medsintez plant innovations. Reportage NVK. 2018

The Medsintez plant. Today and prospects. Reportage NVK. 2018

Visit of the delegation of pharmaceutical manufacturers of France to the production of "Plant Medsintez". Reportage ECHO-TV 24. 2015